Cann is the first Australian company to secure the necessary
licences to undertake research and to cultivate cannabis for
human medicinal and research purposes under the Australian
Government’s new medicinal cannabis regulatory system.
Cann is building an Australian based business intended to take
advantage of opportunities relating to the emerging medicinal
cannabis industry.
Cann has established facilities and systems which can cultivate
medicinal cannabis in accordance with the requirements under the
Narcotic Drugs Act 1967 (ND Act). In due course, Cann intends to
extend its operational activities to the manufacturing of medicinal
cannabis products.
Cann’s vision is to be a leading developer and supplier of cannabis,
cannabis resin and medicinal cannabis products into the Australian
market, and to supply overseas markets as those opportunities
become available. |
